Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients
|ClinicalTrials.gov Identifier: NCT00501163|
Recruitment Status : Unknown
Verified March 2010 by Washington University School of Medicine.
Recruitment status was: Recruiting
First Posted : July 13, 2007
Last Update Posted : March 18, 2010
Participants will be asked to do the following:
- A screening session in which you will take part in a diagnostic interview that will take about 2-3 hours to complete and will address your medical history. If you've recently participated in one of Dr. Haupt's or Dr. Newcomer's studies (HRPO #03-1281, 01-0134, or 04-0191) you may not have to complete this screening interview.
- An ultrasound test of your heart and blood vessels where an ultrasound machine will use sound waves to create images that allow the main blood vessels in your neck to be examined. You will be lying down for the procedure, and a colorless gel will be applied to the side of your neck where the handheld probe (called a transducer) will be placed. The transducer will then be gently moved over each side of your neck. This procedure will take approximately 30 minutes.
- A magnetic resonance image (MRI) study where the amount of fat in your liver will be measured. The MRI involves having your body painlessly scanned inside a tubular machine, while lying on a table for about 45 minutes.
- Some routine blood tests to assess glucose (sugar) and lipid (fat) control and liver function, as well as an additional hepatitis screen if you have a history of hepatitis. You will go to the Intensive Research Unit (IRU) or Clinical Trials Unit (CTU) after an 8 to 10-hour overnight fast (except water). Approximately 42 ml (3 tablespoons) of blood will be obtained from you, and you will also have your height, weight, blood pressure, and waist and hip measurements taken. This will take approximately one hour.
- A dual energy x-ray absorptiometry (DEXA) scan to measure your body fat and body muscle content. The DEXA scan involves lying on a table in a private room wearing a hospital gown for about 15 minutes while a machine silently measures the amount of fat in your body. The DEXA scan is part of the research study and gives the researcher a picture of how much fat is in your body.
|Condition or disease|
|Schizophrenia Cardiovascular Disease|
|Study Type :||Observational|
|Estimated Enrollment :||90 participants|
|Official Title:||Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients|
|Study Start Date :||August 2007|
|Estimated Primary Completion Date :||July 2010|
|Estimated Study Completion Date :||July 2010|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00501163
|Contact: Elizabeth Westerhaus, MAemail@example.com|
|Contact: Julie Schweigerfirstname.lastname@example.org|
|United States, Missouri|
|Washington University School of Medicine||Recruiting|
|St. Louis, Missouri, United States, 63110|
|Principal Investigator: Daniel W Haupt, MD|
|Principal Investigator:||Daniel W Haupt, MD||Washington University School of Medicine|